Hepatic stellate cells: Partners in crime for liver metastases?
Open Access
- 21 April 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 54 (2), 707-713
- https://doi.org/10.1002/hep.24384
Abstract
Hepatic stellate cells (HSCs) were recently postulated as a component of the prometastatic liver microenvironment, because they can transdifferentiate into highly proliferative and motile myofibroblasts that are implicated in the desmoplastic reaction and metastatic growth. This review focuses on bidirectional interactions between tumor cells and HSCs in the liver microenvironment and discusses mechanisms whereby tumor‐derived factors activate HSCs, and in turn, activated HSCs promote metastatic growth. Bidirectional interactions between tumors and HSCs may function as an “amplification loop” to further enhance metastatic growth in the liver. The activation of HSCs is a complex process regulated by multiple factors such as transforming growth factor‐β and platelet‐derived growth factor signaling pathways, which may present as therapeutic targets in the prevention and treatment of liver metastases. Conclusion: HSCs may present a new therapeutic target in the treatment of liver metastases. Targeting HSCs and/or myofibroblasts with transforming growth factor‐β or platelet‐derived growth factor antagonists in coordination with chemotherapy, radiotherapy, or surgery may prove to be effective at reducing liver metastases and increasing the survival benefit of patients by targeting both tumor cells and the tumor microenvironment. (HEPATOLOGY 2011;)Keywords
This publication has 55 references indexed in Scilit:
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targetsSeminars in Cancer Biology, 2011
- The sensors and regulators of cell–matrix surveillance in anoikis resistance of tumorsInternational Journal of Cancer, 2010
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- The Prometastatic Microenvironment of the LiverCancer Microenvironment, 2008
- Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen speciesHepatology, 2008
- Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashionJournal of Cellular Physiology, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early MicrometastasesThe American Journal of Pathology, 1998